LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.410
0.00 (0.00%)
At close: Apr 28, 2026
LSL Pharma Group Revenue
LSL Pharma Group had revenue of 7.58M CAD in the quarter ending September 30, 2025, with 88.97% growth. This brings the company's revenue in the last twelve months to 26.80M, up 69.41% year-over-year. In the year 2024, LSL Pharma Group had annual revenue of 17.75M with 76.98% growth.
Revenue (ttm)
26.80M
Revenue Growth
+69.41%
P/S Ratio
1.85
Revenue / Employee
144.11K
Employees
186
Market Cap
49.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| C21 Investments | 45.62M |
| ZYUS Life Sciences | 465.00K |
| Leef Brands | 47.70M |
| Rubicon Organics | 59.45M |
| BioNxt Solutions | 15.82K |
| Planet 13 Holdings | 141.74M |
| iAnthus Capital Holdings | 196.87M |
| Optimi Health | 193.60K |